Metastatic Gastric Adenocarcinoma Recruiting Phase 2 Trials for Docetaxel (DB01248)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04840264Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel ObstructionTreatment
NCT04781686Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric CancerTreatment